Annual Current Liabilities
$42.57 M
-$54.30 M-56.05%
31 December 2023
Summary:
Inovio Pharmaceuticals annual total current liabilities is currently $42.57 million, with the most recent change of -$54.30 million (-56.05%) on 31 December 2023. During the last 3 years, it has risen by +$864.20 thousand (+2.07%). INO annual current liabilities is now -56.05% below its all-time high of $96.87 million, reached on 31 December 2022.INO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$23.50 M
-$2.90 M-10.99%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly total current liabilities is currently $23.50 million, with the most recent change of -$2.90 million (-10.99%) on 30 September 2024. Over the past year, it has dropped by -$20.21 million (-46.24%). INO quarterly current liabilities is now -82.07% below its all-time high of $131.06 million, reached on 30 June 2022.INO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.0% | -46.2% |
| 3 y3 years | +2.1% | -54.3% |
| 5 y5 years | +20.6% | +20.2% |
INO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.0% | +2.1% | -82.1% | +0.4% |
| 5 y | 5 years | -56.0% | +33.1% | -82.1% | +20.2% |
| alltime | all time | -56.0% | +3573.7% | -82.1% | +3007.1% |
Inovio Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.50 M(-11.0%) |
| June 2024 | - | $26.40 M(+12.8%) |
| Mar 2024 | - | $23.40 M(-45.0%) |
| Dec 2023 | $42.57 M(-56.1%) | $42.57 M(-2.6%) |
| Sept 2023 | - | $43.71 M(-15.8%) |
| June 2023 | - | $51.93 M(-5.8%) |
| Mar 2023 | - | $55.15 M(-43.1%) |
| Dec 2022 | $96.87 M(+47.3%) | $96.87 M(+2.1%) |
| Sept 2022 | - | $94.91 M(-27.6%) |
| June 2022 | - | $131.06 M(+120.8%) |
| Mar 2022 | - | $59.36 M(-9.7%) |
| Dec 2021 | $65.74 M(+57.6%) | $65.74 M(+28.0%) |
| Sept 2021 | - | $51.38 M(-0.7%) |
| June 2021 | - | $51.75 M(+24.6%) |
| Mar 2021 | - | $41.54 M(-0.4%) |
| Dec 2020 | $41.71 M(+30.4%) | $41.71 M(+1.1%) |
| Sept 2020 | - | $41.26 M(+8.6%) |
| June 2020 | - | $37.98 M(+17.6%) |
| Mar 2020 | - | $32.29 M(+1.0%) |
| Dec 2019 | $31.99 M(-9.4%) | $31.99 M(+63.7%) |
| Sept 2019 | - | $19.55 M(-18.8%) |
| June 2019 | - | $24.08 M(-12.2%) |
| Mar 2019 | - | $27.41 M(-22.3%) |
| Dec 2018 | $35.30 M(-0.3%) | $35.30 M(+26.1%) |
| Sept 2018 | - | $28.00 M(-1.4%) |
| June 2018 | - | $28.41 M(-44.7%) |
| Mar 2018 | - | $51.38 M(+45.1%) |
| Dec 2017 | $35.41 M(-19.2%) | $35.41 M(+6.1%) |
| Sept 2017 | - | $33.36 M(+21.8%) |
| June 2017 | - | $27.38 M(-31.5%) |
| Mar 2017 | - | $40.00 M(-8.7%) |
| Dec 2016 | $43.82 M(+39.3%) | $43.82 M(+5.9%) |
| Sept 2016 | - | $41.37 M(+16.6%) |
| June 2016 | - | $35.49 M(+6.3%) |
| Mar 2016 | - | $33.40 M(+6.1%) |
| Dec 2015 | $31.47 M(+123.4%) | $31.47 M(+72.2%) |
| Sept 2015 | - | $18.28 M(+25.9%) |
| June 2015 | - | $14.52 M(+78.0%) |
| Mar 2015 | - | $8.16 M(-42.1%) |
| Dec 2014 | $14.09 M(-51.4%) | $14.09 M(+57.8%) |
| Sept 2014 | - | $8.93 M(-23.1%) |
| June 2014 | - | $11.60 M(-25.8%) |
| Mar 2014 | - | $15.64 M(-46.0%) |
| Dec 2013 | $28.97 M(+245.8%) | $28.97 M(+41.7%) |
| Sept 2013 | - | $20.44 M(+7.2%) |
| June 2013 | - | $19.07 M(+19.4%) |
| Mar 2013 | - | $15.98 M(+90.7%) |
| Dec 2012 | $8.38 M(-24.1%) | $8.38 M(-25.7%) |
| Sept 2012 | - | $11.28 M(+10.2%) |
| June 2012 | - | $10.23 M(-21.4%) |
| Mar 2012 | - | $13.02 M(+17.9%) |
| Dec 2011 | $11.04 M | $11.04 M(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $9.70 M(-2.4%) |
| June 2011 | - | $9.94 M(-29.9%) |
| Mar 2011 | - | $14.18 M(+120.4%) |
| Dec 2010 | $6.44 M(-66.7%) | $6.44 M(+23.2%) |
| Sept 2010 | - | $5.22 M(-7.9%) |
| June 2010 | - | $5.67 M(-67.9%) |
| Mar 2010 | - | $17.69 M(-8.6%) |
| Dec 2009 | $19.35 M(+31.5%) | $19.35 M(-8.9%) |
| Sept 2009 | - | $21.25 M(+6.1%) |
| June 2009 | - | $20.03 M(+32.9%) |
| Mar 2009 | - | $15.07 M(+2.5%) |
| Dec 2008 | $14.71 M(+338.5%) | $14.71 M(+230.2%) |
| Sept 2008 | - | $4.46 M(+25.6%) |
| June 2008 | - | $3.55 M(+24.2%) |
| Mar 2008 | - | $2.85 M(-14.9%) |
| Dec 2007 | $3.35 M(-51.1%) | $3.35 M(+8.0%) |
| Sept 2007 | - | $3.11 M(+4.5%) |
| June 2007 | - | $2.97 M(+9.9%) |
| Mar 2007 | - | $2.71 M(-60.6%) |
| Dec 2006 | $6.86 M(+65.9%) | $6.86 M(+150.8%) |
| Sept 2006 | - | $2.73 M(-4.3%) |
| June 2006 | - | $2.86 M(-11.7%) |
| Mar 2006 | - | $3.24 M(-21.8%) |
| Dec 2005 | $4.14 M(-23.4%) | $4.14 M(+10.3%) |
| Sept 2005 | - | $3.75 M(-22.7%) |
| June 2005 | - | $4.85 M(-8.7%) |
| Mar 2005 | - | $5.31 M(-1.7%) |
| Dec 2004 | $5.40 M(+366.2%) | $5.40 M(+65.0%) |
| Sept 2004 | - | $3.27 M(+78.8%) |
| June 2004 | - | $1.83 M(+122.3%) |
| Mar 2004 | - | $823.80 K(-28.9%) |
| Dec 2003 | $1.16 M(-30.1%) | $1.16 M(+14.9%) |
| Sept 2003 | - | $1.01 M(+33.4%) |
| June 2003 | - | $756.30 K(-14.4%) |
| Mar 2003 | - | $884.00 K(-46.7%) |
| Dec 2002 | $1.66 M(+3.3%) | $1.66 M(+33.2%) |
| Sept 2002 | - | $1.24 M(+5.2%) |
| June 2002 | - | $1.18 M(-9.7%) |
| Mar 2002 | - | $1.31 M(-5.6%) |
| Dec 2001 | $1.61 M(+6.1%) | - |
| Sept 2001 | - | $1.39 M(-7.8%) |
| June 2001 | - | $1.50 M(-0.5%) |
| Mar 2001 | - | $1.51 M(-1.6%) |
| Mar 2001 | $1.51 M(-28.2%) | - |
| Dec 2000 | - | $1.54 M(-2.8%) |
| Sept 2000 | - | $1.58 M(-19.1%) |
| June 2000 | - | $1.96 M(-7.1%) |
| Mar 2000 | $2.11 M(+50.4%) | $2.11 M(+0.3%) |
| Dec 1999 | - | $2.10 M(+23.5%) |
| Sept 1999 | - | $1.70 M(+41.7%) |
| June 1999 | - | $1.20 M(-14.3%) |
| Mar 1999 | $1.40 M | $1.40 M(+27.3%) |
| Dec 1998 | - | $1.10 M |
FAQ
- What is Inovio Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual current liabilities year-on-year change?
- What is Inovio Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly current liabilities year-on-year change?
What is Inovio Pharmaceuticals annual total current liabilities?
The current annual current liabilities of INO is $42.57 M
What is the all time high annual current liabilities for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual total current liabilities is $96.87 M
What is Inovio Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, INO annual total current liabilities has changed by -$54.30 M (-56.05%)
What is Inovio Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of INO is $23.50 M
What is the all time high quarterly current liabilities for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly total current liabilities is $131.06 M
What is Inovio Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, INO quarterly total current liabilities has changed by -$20.21 M (-46.24%)